Germany’s BioNTech has said it is not interested in a takeover after it gained clearance to begin a high-profile COVID-19 coronavirus vaccine trial with Pfizer.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,